Switch to:
More From Other Websites
ENTEROMEDICS INC Financials Aug 20 2016
ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events,... Aug 17 2016
EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors Aug 17 2016
EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors Aug 17 2016
EnteroMedics Announces Publication of 24 Month ReCharge Clinical Study Data in Obesity Surgery Aug 15 2016
EnteroMedics Announces Publication of 24 Month ReCharge Clinical Study Data in Obesity Surgery Aug 15 2016
ENTEROMEDICS INC Files SEC form 10-Q, Quarterly Report Aug 12 2016
EnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
EnteroMedics reports 2Q loss Aug 04 2016
ENTEROMEDICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 04 2016
EnteroMedics Reports Second Quarter 2016 Financial Results Aug 04 2016
EnteroMedics Reports Second Quarter 2016 Financial Results Aug 04 2016
Pharma and tech converge in "fantastic voyage" to fight disease Aug 01 2016
Pharma and tech converge in 'fantastic voyage' to fight disease Aug 01 2016
GSK and Google parent forge $715 mln bioelectronic medicines firm Aug 01 2016
ENTEROMEDICS INC Files SEC form 8-K, Other Events Jul 20 2016
ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Jul 15 2016
Cheap Stocks: These Aren't Necessarily a Lucky 7 Jul 13 2016
ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 06 2016
EnteroMedics Highlights Recent Patient Success with vBloc® Therapy in Combination with vBloc®... Jun 29 2016
EnteroMedics Highlights Recent Patient Success with vBloc® Therapy in Combination with vBloc®... Jun 29 2016
ENTEROMEDICS INC Files SEC form 8-K, Other Events Jun 28 2016
EnteroMedics downgraded by ROTH Capital Jun 09 2016
EnteroMedics Announces First-of-its-Kind Procedure with vBloc® Therapy Used as Adjunctive Rescue... Jun 01 2016
EnteroMedics Announces First-of-its-Kind Procedure with vBloc® Therapy Used as Adjunctive Rescue... Jun 01 2016
EnteroMedics to Host vBloc® Commercialization Update Conference Call May 23 2016
EnteroMedics to Host vBloc® Commercialization Update Conference Call May 23 2016
ENTEROMEDICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing... May 13 2016
ENTEROMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers May 10 2016
ENTEROMEDICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of... May 06 2016
EnteroMedics Reports First Quarter 2016 Financial Results May 05 2016
EnteroMedics Reports First Quarter 2016 Financial Results May 05 2016
EnteroMedics Announces Closing of $6.25 Million Third Tranche of Previously-Announced Convertible... May 03 2016
EnteroMedics Announces Closing of $6.25 Million Third Tranche of Previously-Announced Convertible... May 03 2016
EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy... May 02 2016
Weight Loss Surgery Foundation of America to Include EnteroMedics vBloc® Therapy as Part of the... Apr 21 2016
EnteroMedics Announces Publication of Results Showing Significantly Greater Weight Loss in vBloc®... Apr 05 2016
EnteroMedics reports 4Q loss Feb 17 2016
EnteroMedics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Jan 22 2016
EnteroMedics Announces Closing of $11 Million Tranche from Previously-Announced Convertible Notes... Jan 13 2016
EnteroMedics Announces Senior Level Appointments, New Commercial Operations Organization Structure Jan 06 2016
EnteroMedics Announces Publication in SOARD of ASMBS Position Statement on Vagal Blocking Therapy... Jan 05 2016
EnteroMedics Announces 1-for-15 Reverse Split Dec 23 2015
EnteroMedics to Host Year-end Company Update Conference Call Dec 08 2015
EnteroMedics to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum Nov 11 2015
EnteroMedics reports 3Q loss Nov 09 2015
EnteroMedics Reports Third Quarter 2015 Financial Results and Commercial Progress Update Nov 09 2015
EnteroMedics Announces $25.0 million Registered Direct Offering of Convertible Notes Nov 05 2015
EnteroMedics reports 2Q loss Aug 06 2015
EnteroMedics reports 4Q loss Feb 18 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK